INS and Alzheimer disease: Given the rising acknowledgment of insulin resistance as an early pathological key step in AD and PD, we have devoted a stand-alone section to the insulin-re-sensitizing mechanisms of GLP-1R agonists (see section “Insulin resistance and the neuronal energy metabolism” and Figure 1).